2020
DOI: 10.1089/cren.2019.0076
|View full text |Cite
|
Sign up to set email alerts
|

Kidney Stone Dissolution Therapy in Phosphate Stones: A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…The medical management of uric lithiasis (calculation of pure uric acid and mixed calculation of uric acid and calcium oxalate) therefore requires the maintenance of a diuresis greater than two liters per 24 hours, but also an increase of urine pH, with the objective of a urine pH between 6.2 and 6.8 for preventive medical treatment, and 7 to 7.2 for dissolution of uric acid stones (pure) in place [22]. In our study, uric acid is very remarkable and ahead of calcium oxalate with a rate of 46.80%, which requires in-depth studies to find the causes of the predominance of uric acid in the urine of lithiasics in the Tissemsilt region.…”
Section: Uric Acidsmentioning
confidence: 99%
“…The medical management of uric lithiasis (calculation of pure uric acid and mixed calculation of uric acid and calcium oxalate) therefore requires the maintenance of a diuresis greater than two liters per 24 hours, but also an increase of urine pH, with the objective of a urine pH between 6.2 and 6.8 for preventive medical treatment, and 7 to 7.2 for dissolution of uric acid stones (pure) in place [22]. In our study, uric acid is very remarkable and ahead of calcium oxalate with a rate of 46.80%, which requires in-depth studies to find the causes of the predominance of uric acid in the urine of lithiasics in the Tissemsilt region.…”
Section: Uric Acidsmentioning
confidence: 99%
“…But in recent years, treatment has become less common because of potential risk concerns and the development of less invasive stone surgery. Despite the Food and Drug Administration reapproval of Renacidin's use, less information about chemolysis is now accessible (7). The purpose of this research is to review the available information about overview of oral chemolysis types and its effectiveness in treating kidney stones.…”
Section: Introductionmentioning
confidence: 99%